| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SLQTSelectQuote, Inc. | 293.87M | 1.67 | 125.56 | 15.5% | 3.95% | 11.28% | 0.72 | |
| GOCOGoHealth, Inc. | 38.62M | 2.40 | -3.64 | 8.74% | -26.96% | -0.64% | 1.15 |
| Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 233.69M | 337.47M | 529.34M | 929.98M | 764.04M | 1B | 1.32B | 1.53B |
| Revenue Growth % | - | 0.44% | 0.57% | 0.76% | -0.18% | 0.31% | 0.32% | 0.15% |
| Medical Costs & Claims | 83.34M | 104.42M | 167.4M | 270.71M | 455.7M | 527.49M | 723.8M | 935.47M |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - |
| Gross Profit | 150.35M | 233.05M | 361.94M | 659.27M | 308.35M | 475.36M | 597.97M | 591.13M |
| Gross Margin % | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 0.55% | 0.55% | 0.82% | -0.53% | 0.54% | 0.26% | -0.01% |
| Operating Expenses | 107.19M | 136.76M | 231.79M | 467.03M | 654.35M | 463.78M | 533.42M | 522.63M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 3.47M | 4.7M | 7.99M | 16.14M | 24.72M | 27.88M | 25M | 20.46M |
| Combined Ratio % | - | - | - | - | - | - | - | - |
| Operating Income | 43.16M | 96.29M | 130.15M | 192.24M | -346.01M | 11.58M | 64.55M | 68.5M |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Operating Income Growth % | - | 1.23% | 0.35% | 0.48% | -2.8% | 1.03% | 4.57% | 0.06% |
| EBITDA | 46.62M | 100.99M | 138.15M | 208.38M | -321.29M | 39.46M | 89.55M | 88.96M |
| EBITDA Margin % | - | - | - | - | - | - | - | - |
| Interest Expense | 929K | 1.66M | 24.59M | 29.32M | 43.59M | 80.61M | 93.55M | 79.39M |
| Non-Operating Income | 709K | 15K | 1.57M | 4.9M | 202K | 121K | 65K | -59.4M |
| Pretax Income | 41.52M | 94.61M | 103.99M | 158.01M | -389.81M | -69.14M | -29.07M | 48.51M |
| Pretax Margin % | - | - | - | - | - | - | - | - |
| Income Tax | 6.62M | 22.03M | 24.5M | 33.16M | -92.3M | -10.6M | 5.06M | 931K |
| Effective Tax Rate % | - | - | - | - | - | - | - | - |
| Net Income | 34.9M | 72.58M | 79.48M | 124.86M | -297.5M | -58.54M | -34.13M | 47.58M |
| Net Margin % | - | - | - | - | - | - | - | - |
| Net Income Growth % | - | 1.08% | 0.1% | 0.57% | -3.38% | 0.8% | 0.42% | 2.39% |
| EPS (Diluted) | 0.25 | 0.45 | 0.49 | 0.75 | -1.81 | -0.35 | -0.20 | 0.01 |
| EPS Growth % | - | 0.8% | 0.09% | 0.53% | -3.41% | 0.81% | 0.43% | 1.07% |
| EPS (Basic) | 0.26 | 0.45 | 0.49 | 0.77 | -1.81 | -0.35 | -0.20 | 0.14 |
| Diluted Shares Outstanding | 138.21M | 162.19M | 162.19M | 165.54M | 164.04M | 166.14M | 168.52M | 181.9M |
| Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 297.56M | 406.94M | 1.13B | 1.42B | 1.29B | 1.22B | 1.19B | 1.25B |
| Asset Growth % | - | 0.37% | 1.77% | 0.26% | -0.09% | -0.05% | -0.02% | 0.05% |
| Total Investment Assets | 196.09M | 279.49M | 461.75M | 0 | 0 | 0 | 723.97M | 820.08M |
| Long-Term Investments | 196.09M | 279.49M | 461.75M | 0 | 0 | 0 | 723.97M | 820.08M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 83.57M | 102.96M | 513.83M | 483.42M | 402.77M | 363.22M | 332.92M | 341.04M |
| Cash & Equivalents | 958K | 570K | 368.87M | 286.45M | 141M | 83.16M | 42.69M | 32.4M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 3.59M | 6.45M | 828K | 0 | 0 | 0 | 5.03M | 25.18M |
| Goodwill & Intangibles | 6.29M | 10.26M | 74.65M | 121.3M | 76.69M | 54.08M | 53.61M | 46.47M |
| Goodwill | 5.36M | 5.36M | 46.58M | 68.02M | 29.14M | 29.14M | 29.44M | 29.44M |
| Intangible Assets | 929K | 4.89M | 28.07M | 53.28M | 47.56M | 24.94M | 24.17M | 17.03M |
| PP&E (Net) | 11.08M | 13.76M | 22.15M | 60.92M | 69.82M | 51.02M | 42.41M | 39.21M |
| Other Assets | 196.62M | 279.96M | 1.41M | 758.21M | 740.77M | 750.94M | 41M | 2.55M |
| Total Liabilities | 109.63M | 143.69M | 582.36M | 756.82M | 898.95M | 872.28M | 877.11M | 673.84M |
| Total Debt | 19.83M | 25.68M | 311.92M | 505.3M | 745.06M | 731.8M | 713.92M | 415.91M |
| Net Debt | 18.87M | 25.11M | -56.95M | 218.84M | 604.07M | 648.64M | 671.23M | 383.51M |
| Long-Term Debt | 19.75M | 21.65M | 311.81M | 459.04M | 698.42M | 664.63M | 637.48M | 316.59M |
| Short-Term Debt | 0 | 3.92M | 49K | 2.36M | 7.17M | 33.88M | 45.85M | 68.52M |
| Total Current Liabilities | 24.28M | 33.22M | 95.81M | 108.82M | 113.51M | 137.26M | 174.59M | 212.91M |
| Accounts Payable | -33K | 7.63M | 22.89M | 34.08M | 24.77M | 27.58M | 36.59M | 59.2M |
| Deferred Revenue | 3.3M | 2.02M | 1.74M | 5.08M | 8.03M | 2.83M | 12.72M | 698K |
| Other Current Liabilities | 1.31M | 1.33M | 48.91M | 41.15M | 42.15M | 50.67M | 16.99M | 65.81M |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 5.94M | 7.49M | 14.58M | 11.72M | 2.86M | 2.83M | 1.81M | 80.48M |
| Total Equity | 187.93M | 263.25M | 545.69M | 667.04M | 391.11M | 346.97M | 316.8M | 575.52M |
| Equity Growth % | - | 0.4% | 1.07% | 0.22% | -0.41% | -0.11% | -0.09% | 0.82% |
| Shareholders Equity | 187.93M | 263.25M | 545.69M | 667.04M | 391.11M | 346.97M | 316.8M | 575.52M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 129.47M | 200.45M | -2.79M | 120.4M | -177.1M | -235.64M | -269.77M | -222.19M |
| Common Stock | 1.1M | 1.15M | 1.62M | 1.64M | 1.64M | 1.67M | 1.69M | 1.73M |
| Accumulated OCI | -10.26M | 0 | -1.25M | 229K | 11.72M | 13.68M | 4.11M | 0 |
| Return on Equity (ROE) | 0.19% | 0.32% | 0.2% | 0.21% | -0.56% | -0.16% | -0.1% | 0.11% |
| Return on Assets (ROA) | 0.12% | 0.21% | 0.1% | 0.1% | -0.22% | -0.05% | -0.03% | 0.04% |
| Equity / Assets | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.11x | 0.10x | 0.57x | 0.76x | 1.91x | 2.11x | 2.25x | 0.72x |
| Book Value per Share | 1.36 | 1.62 | 3.36 | 4.03 | 2.38 | 2.09 | 1.88 | 3.16 |
| Tangible BV per Share | - | - | - | - | - | - | - | - |
| Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -4.85M | 113K | -61.78M | -115.44M | -338.31M | -19.38M | 15.24M | -11.67M |
| Operating CF Growth % | - | 1.02% | -547.69% | -0.87% | -1.93% | 0.94% | 1.79% | -1.77% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - |
| Net Income | 34.9M | 72.58M | 81.15M | 124.86M | -297.5M | -58.54M | -34.13M | 25.03M |
| Depreciation & Amortization | 3.47M | 4.7M | 7.99M | 16.14M | 24.72M | 27.88M | 25M | 20.46M |
| Stock-Based Compensation | 67K | 86K | 9.5M | 5.17M | 7.05M | 11.31M | 13.82M | 18.36M |
| Deferred Taxes | 6.58M | 21.99M | 25.01M | 33.01M | -92.72M | -11.18M | 1.16M | 1.85M |
| Other Non-Cash Items | 770K | 344K | 3.24M | 11.91M | 58.73M | 43.67M | 28.9M | -5.05M |
| Working Capital Changes | -50.63M | -99.59M | -188.66M | -306.53M | -38.6M | -32.52M | -19.51M | -72.31M |
| Cash from Investing | -6.02M | -8.64M | -51.37M | -64.02M | -42.58M | -9.13M | -14.85M | -11.31M |
| Capital Expenditures | -6.02M | -8.64M | -15.55M | -14.91M | -24.8M | -1.45M | -3.38M | -2.19M |
| Acquisitions | 0 | 0 | -35.82M | -41.03M | -6.93M | 0 | -3.43M | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 | -1M | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -624K | -4.71M | 3K | -8.08M | -9.85M | -7.68M | -8.03M | -9.12M |
| Cash from Financing | 11.48M | 8.13M | 481.45M | 97.04M | 235.43M | -29.34M | -40.86M | 17.36M |
| Dividends Paid | -1.88M | -1.96M | -275M | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -441K | -34K | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Issued | 0 | 0 | 340.2M | 0 | 0 | 0 | 0 | 330.88M |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K |
| Other Financing | 462K | 4.04M | -9.35M | -47.34M | -2.8M | -11.35M | -1.82M | -7.51M |
| Net Change in Cash | 616K | -388K | 368.3M | -82.42M | -145.46M | -57.84M | -40.47M | -5.62M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 342K | 958K | 570K | 368.87M | 286.45M | 141M | 83.16M | 42.69M |
| Cash at End | 958K | 570K | 368.87M | 286.45M | 141M | 83.16M | 42.69M | 37.07M |
| Free Cash Flow | -10.87M | -8.52M | -77.33M | -138.43M | -372.96M | -28.5M | 3.57M | -13.86M |
| FCF Growth % | - | 0.22% | -8.07% | -0.79% | -1.69% | 0.92% | 1.13% | -4.88% |
| FCF Margin % | - | - | - | - | - | - | - | - |
| FCF per Share | -0.08 | -0.05 | -0.48 | -0.84 | -2.27 | -0.17 | 0.02 | -0.08 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 81.53% | 71.47% | 75.41% | 79.33% | 145.29% | 98.84% | 95.12% | 95.51% |
| Medical Cost Ratio | 35.66% | 30.94% | 31.62% | 29.11% | 59.64% | 52.6% | 54.76% | 61.28% |
| Return on Equity (ROE) | 18.57% | 32.17% | 19.65% | 20.59% | -56.23% | -15.86% | -10.28% | 10.66% |
| Return on Assets (ROA) | 11.73% | 20.6% | 10.36% | 9.79% | -21.92% | -4.67% | -2.83% | 3.89% |
| Equity / Assets | 63.16% | 64.69% | 48.37% | 46.85% | 30.32% | 28.46% | 26.53% | 46.07% |
| Book Value / Share | 1.36 | 1.62 | 3.36 | 4.03 | 2.38 | 2.09 | 1.88 | 3.16 |
| Debt / Equity | 0.11x | 0.10x | 0.57x | 0.76x | 1.91x | 2.11x | 2.25x | 0.72x |
| Revenue Growth | - | 44.41% | 56.86% | 75.69% | -17.84% | 31.26% | 31.8% | 15.5% |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Service | - | - | 6.62M | 653.47M | 856.92M | 797.84M |
| Service Growth | - | - | - | 9765.19% | 31.13% | -6.89% |
| Pharmacy | - | - | - | 239.55M | 464.85M | 728.75M |
| Pharmacy Growth | - | - | - | - | 94.06% | 56.77% |
| Product and Service, Other | 780K | 5.3M | 6.56M | 109.83M | 4.17M | 4.17M |
| Product and Service, Other Growth | - | 579.23% | 23.82% | 1574.25% | -96.20% | -0.07% |
| Product | - | - | - | - | - | - |
| Product Growth | - | - | - | - | - | - |
| Commission | 534K | 2M | - | - | - | - |
| Commission Growth | - | 275.28% | - | - | - | - |
SelectQuote, Inc. (SLQT) has a price-to-earnings (P/E) ratio of 125.6x. This suggests investors expect higher future growth.
SelectQuote, Inc. (SLQT) grew revenue by 15.5% over the past year. This is strong growth.
Yes, SelectQuote, Inc. (SLQT) is profitable, generating $61.7M in net income for fiscal year 2025 (3.1% net margin).
SelectQuote, Inc. (SLQT) has a return on equity (ROE) of 10.7%. This is reasonable for most industries.
SelectQuote, Inc. (SLQT) has a combined ratio of 95.5%. A ratio below 100% indicates underwriting profitability.